Paradigm shifts: Early initiation of high-efficacy disease-modifying treatment in multiple sclerosis-Reference-Cited by-同舟云学术

Paradigm shifts: Early initiation of high-efficacy disease-modifying treatment in multiple sclerosis

Published:2021-09 Issue:10 Volume:27 Page:1473-1476
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Hartung Hans-Peter¹,Meuth Sven G²,Thompson Alan J³^ORCID

Affiliation:

1. Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany/Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia; Department of Neurology, Medical University of Vienna, Vienna, Austria

2. Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany

3. Queen Square MS Centre, UCL Institute of Neurology, London, UK

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/13524585211033190

Reference13 articles.

1. Treatment of multiple sclerosis — success from bench to bedside

2. Multiple sclerosis under the spotlight

3. Assessing long-term effectiveness of MS treatment — a matter of debate

4. Cumulative effects of therapies on disability in relapsing multiple sclerosis

5. Importance of early treatment initiation in the clinical course of multiple sclerosis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review;Frontiers in Immunology;2024-04-05

2. Therapeutic inertia in the management of neuromyelitis optica spectrum disorder;Frontiers in Neurology;2024-02-21

3. Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study;Multiple Sclerosis and Related Disorders;2024-02

4. “A qualitative study of multiple sclerosis specialists’ experiences and perspectives in managing family planning in people with multiple sclerosis”;Multiple Sclerosis and Related Disorders;2024-02

5. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-11-30